Sutimlimab ( DrugBank: Sutimlimab )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
61	自己免疫性溶血性貧血	4

61. 自己免疫性溶血性貧血

臨床試験数 : 146 / 薬物数 : 131 - (DrugBank : 59) / 標的遺伝子数 : 28 - 標的パスウェイ数 : 158

diseases per page:

Showing 1 to 4 of 4 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	JPRN-jRCT2031210392	07/12/2021	27/10/2021	Sutimlimab(BIVV009) for the adult participants with cold agglutinin disease (CAD) who have completed ...	An open-label study for sutimlimabin participants with cold agglutinin disease (CAD) who have comple ...	Cold Agglutinin Disease	Drug: sutimlimab(BIVV009) Pharmaceutical Form: solution for injection, Route of Administration: intra ...	Tanaka Tomoyuki	NULL	Not Recruiting	>= 20age old	Not applicable	Both	7	Phase 3	Japan
2	NCT05132127 (ClinicalTrials.gov)	November 11, 2021	11/11/2021	Sutimlimab(BIVV009) for the Adult Participants With Cold Agglutinin Disease (CAD) Who Have Completed ...	An Open-label Study for Sutimlimabin Participants With Cold Agglutinin Disease (CAD) Who Have Comple ...	Cold Agglutinin Disease	Drug: sutimlimab	Sanofi	NULL	Completed	20 Years	N/A	All	7	Phase 3	Japan
3	NCT03347422 (ClinicalTrials.gov)	March 17, 2018	16/11/2017	A Study to Assess the Efficacy and Safety of BIVV009 (Sutimlimab) in Participants With Primary Cold ...	A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of S ...	Cold Agglutinin Disease	Drug: sutimlimab (BIVV009);Drug: placebo	Bioverativ, a Sanofi company	NULL	Completed	18 Years	N/A	All	42	Phase 3	United States;Australia;Austria;Belgium;Canada;France;Germany;Israel;Italy;Japan;Netherlands;Norway; ...
4	NCT03347396 (ClinicalTrials.gov)	March 5, 2018	16/11/2017	A Study to Assess the Efficacy and Safety of BIVV009 (Sutimlimab) in Participants With Primary Cold ...	A Phase 3, Pivotal, Open-label, Multicenter Study to Assess the Efficacy and Safety of Sutimlimabin ...	Agglutinin Disease, Cold	Drug: Sutimlimab	Bioverativ, a Sanofi company	NULL	Completed	18 Years	N/A	All	20	Phase 3	United States;Australia;Austria;Belgium;Canada;France;Germany;Israel;Italy;Japan;Netherlands;Norway; ...

First Previous1Next Last